Copyright
©The Author(s) 2019.
World J Clin Oncol. Oct 24, 2019; 10(10): 318-339
Published online Oct 24, 2019. doi: 10.5306/wjco.v10.i10.318
Published online Oct 24, 2019. doi: 10.5306/wjco.v10.i10.318
Figure 1 Stereotactic body radiation therapy dose distribution for a single brain metastasis from non-small cell lung cancer.
Planning computed tomography fused with magnetic resonance images. A: Coronal view; B: Axial view; C: Sagittal view.
Figure 2 Example of stereotactic body radiation therapy plan for adrenal gland metastases from non-small cell lung cancer with 95% isodose highlighted in dose heatmap.
A: Coronal view; B: Axial view.
Figure 3 Image capture from stereotactic body radiation therapy planning session showing concentration of radiation dose to the liver metastases.
Planning computed tomography fused with magnetic resonance images. A: Coronal view; B: Axial view.
Figure 4 Example of stereotactic body radiation therapy planning using 4D-computed tomography for a patient with right lung metastases from non-small cell lung cancer.
A: Isodose distribution in the axial plane; B: Isodose distribution in the sagittal plane; C: Isodose distribution in the coronal plane.
- Citation: Couñago F, Luna J, Guerrero LL, Vaquero B, Guillén-Sacoto MC, González-Merino T, Taboada B, Díaz V, Rubio-Viqueira B, Díaz-Gavela AA, Marcos FJ, del Cerro E. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World J Clin Oncol 2019; 10(10): 318-339
- URL: https://www.wjgnet.com/2218-4333/full/v10/i10/318.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i10.318